Annual CFI
$15.88 M
-$3.65 M-18.71%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual cash flow from investing activities is $15.88 million, with the most recent change of -$3.65 million (-18.71%) on December 31, 2023.
- During the last 3 years, CMMB annual CFI has risen by +$15.94 million (+25711.29%).
- CMMB annual CFI is now -18.71% below its all-time high of $19.53 million, reached on December 31, 2022.
Performance
CMMB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
N/A
September 1, 2024
Summary
- CMMB quarterly cash flow from investing activities is not available.
Performance
CMMB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
September 1, 2024
Summary
- CMMB TTM cash flow from investing activities is not available.
Performance
CMMB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CMMB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.7% | - | - |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | +10000.0% | - | - |
CMMB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.7% | +135.1% | ||||
| 5 y | 5-year | -18.7% | +135.1% | ||||
| alltime | all time | -18.7% | +135.1% |
Chemomab Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $15.88 M(-18.7%) | - | - |
| Jun 2023 | - | -$4.27 M(-129.6%) | $25.59 M(-19.0%) |
| Mar 2023 | - | $14.43 M(+54.4%) | $31.58 M(+61.7%) |
| Dec 2022 | $19.53 M(-143.2%) | $9.35 M(+53.9%) | $19.53 M(-307.8%) |
| Sep 2022 | - | $6.07 M(+251.7%) | -$9.40 M(-54.1%) |
| Jun 2022 | - | $1.73 M(-27.5%) | -$20.47 M(-52.2%) |
| Mar 2022 | - | $2.38 M(-112.2%) | -$42.80 M(-5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$45.19 M(>+9900.0%) | -$19.58 M(+291.6%) | -$45.19 M(+76.5%) |
| Sep 2021 | - | -$5.00 M(-75.7%) | -$25.61 M(+24.1%) |
| Jun 2021 | - | -$20.60 M(>+9900.0%) | -$20.63 M(>+9900.0%) |
| Mar 2021 | - | -$2000.00(-33.3%) | -$54.00 K(-12.9%) |
| Dec 2020 | -$62.00 K | -$3000.00(-85.0%) | -$62.00 K(+5.1%) |
| Sep 2020 | - | -$20.00 K(-31.0%) | -$59.00 K(+51.3%) |
| Jun 2020 | - | -$29.00 K(+190.0%) | -$39.00 K(+290.0%) |
| Mar 2020 | - | -$10.00 K | -$10.00 K |
FAQ
- What is Chemomab Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual CFI year-on-year change?
- What is the all time high quarterly CFI for Chemomab Therapeutics?
- What is the all time high TTM CFI for Chemomab Therapeutics?
What is Chemomab Therapeutics annual cash flow from investing activities?
The current annual CFI of CMMB is $15.88 M
What is the all time high annual CFI for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual cash flow from investing activities is $19.53 M
What is Chemomab Therapeutics annual CFI year-on-year change?
Over the past year, CMMB annual cash flow from investing activities has changed by -$3.65 M (-18.71%)
What is the all time high quarterly CFI for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly cash flow from investing activities is $14.43 M
What is the all time high TTM CFI for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM cash flow from investing activities is $31.58 M